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Background: Stakeholder roles in the application of evidence are influenced by context, the nature of the
evidence, the policy development process, and stakeholder interactions. Past research has highlighted the role of
stakeholders in knowledge translation (KT) without paying adequate attention to the peculiarities of low-income
countries. Here we identify the roles, relations, and interactions among the key stakeholders involved in KT in
Uganda and the challenges that they face.
Methods: This study employed qualitative approaches to examine the roles of and links among various
stakeholders in KT. In-depth interviews were conducted with 21 key informants and focused on the key actors in
KT, their perceived roles, and challenges.
Results: Major stakeholders included civil society organizations with perceived roles of advocacy, community
mobilization, and implementation. These stakeholders may ignore unconvincing evidence. The community’s role
was perceived as advocacy and participation in setting research priorities. The key role of the media was perceived
as knowledge dissemination, but respondents noted that the media may misrepresent evidence if it is received in a
poorly packaged form. The perceived roles of policy makers were evidence uptake, establishing platforms for KT
and stewardship; negative roles included ignoring or even misrepresenting evidence that is not in their favor. The
roles of parliamentarians were perceived as advocacy and community mobilization, but they were noted to pursue
objectives that may not be supported by the evidence. The researchers’ main role was defined as evidence
generation, but focusing disproportionately on academic interests was cited as a concern. The donors’ main role was
defined as funding research and KT, but respondents were concerned about the local relevance of donor-supported
research. Respondents reported that links among stakeholders were weak due to the absence of institutionalized,
inclusive platforms. Challenges facing the stakeholders in the process of KT were identified.
Conclusions: Our investigation revealed the need to consider the roles that various stakeholders are best placed to
play. Links and necessary platforms must be put in place to achieve synergy in KT. Relevant capacities need to be built
to overcome the challenges faced by the various stakeholders.
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Although efforts have been made to improve uptake of
evidence in the development of public health policy, much
remains to be done, especially in low-income countries
(LICs) [1-3]. Several terms have been used for the notion
of uptake of evidence in health policy development,
including knowledge translation (KT), research utilization,
evidence-based decision making, and getting research into
policy and practice. In this article, we use KT as an all-
encompassing term defined as “a dynamic and iterative
process that includes synthesis, dissemination, exchange,
and ethically sound application of knowledge to improve
health, provide more effective health services and products,
and strengthen the health care system” [4].
There is an extensive body of literature on the factors
that facilitate or hinder the uptake of evidence and; several
models for KT have been proposed [5-9]. Sauerborn et al.
highlighted the role of stakeholders in KT, stating that
evidence can only be relevant if it is known and used by
stakeholders [10]. The current study builds upon an earlier
study on KT in Uganda in which we developed a middle
range theory (MRT) of how the uptake of evidence in
health policy development can be improved [11]. MRTs
should be understood here as defined by Merton in 1968 as
“theories that lie between the minor but necessary working
hypotheses (…) and the all-inclusive systematic efforts to
develop a unified theory that will explain all the observed
uniformities of social behavior, social organization, and
social change” [12]. The themes in our MRT that were
previously identified by policy actors as most important
were: (1) institutional strengthening for KT to enhance
ownership and better application of evidence; (2) timely
provision of high-quality, relevant evidence produced by
credible researchers; and (3) partnerships involving all
relevant stakeholders, including communities, throughout
the process of knowledge generation up to its application
[11]. In this article, we focus on the partnerships, roles,
relations, and interactions of key stakeholders involved
in KT. We define partnership as a complementary rela-
tionship that enhances attainment of a given objective and
in which the roles of the various stakeholders are well
identified [6].
Potential stakeholders in KT encompass both the public
and private sectors and have been identified as government
policy makers, politicians, service providers, health
managers, professional bodies and networks, knowledge
brokers, donors, communities, civil society organizations
(CSOs)/non-governmental organizations, and the media.
The literature highlights a multiplicity of potential
roles that can be played by the various stakeholders in
KT. For example, CSOs have the capacity to mobilize
communities to demand policy change, to contribute to
all stages of research, to mobilize resources, and to
disseminate and utilize evidence in implementing theirown programs [13-15]. CSOs are here defined as organized
groups concerned with public interests, including non-
governmental organizations and less formally organized
groups based in local communities [14]. However, the
challenges faced by CSOs include inadequate capacity to
navigate the political terrain and to influence policy,
the service-delivery focus of their operations, financial
constraints, limited capacity to undertake research beyond
evaluation of their programs and pilot programs, weak
links with the research community and dependence on
donors [7,16,17]. Communities have also been identified
as stakeholders because their involvement facilitates the
generation of research results that are more responsive to
local needs [6,18]. However, communities are challenged by
a lack of relevant institutional structures, the weak capacity
of communities, and the costs associated with enabling
their participation [19]. Although Armstrong et al. main-
tain that the roles of CSOs, the media, and pressure groups
in KT remain poorly understood and unexplored [20], the
media have been shown to enjoy major influencing power;
their roles in KT have been stated to be dissemination of
information and social mobilization [10,21,22].
Policy makers influence the degree to which research in-
forms policy development, shape the research prioritization
process, and impact the actual generation of knowledge
[7,21]. In addition, policy makers play a key role in
establishing the required platforms for engagement in KT
and in building partnerships between researchers and
other stakeholders [23]. The roles of politicians have been
identified as mobilization of communities, dissemination
of evidence, and advocacy. However, politicians may
face several challenges, including the pressure to respond
to their constituencies and political ideological agendas
that may influence how they deal with the available
evidence [3,10].
Although researchers intervene as major stakeholders
in the process of KT [10,21,24], they have been criticized
for failing to address policy-relevant questions, for lacking
knowledge of the policy process, for poor packaging of
results, and for possessing limited dissemination skills
[18,21,25,26].
The donors’ main role is funding research, KT activities,
and implementation of research findings [3,21]. However,
Young pointed out that the role of donors in KT can be
both supportive and disruptive [27]. Failure to address
local research priorities and taking control of the research
and policy agendas are among the criticisms leveled against
donors [28,29].
Knowledge brokers are defined as people who link the
various stakeholders through their capacity to disseminate
research in user-friendly packages. However, researchers
have raised concerns regarding the need to evaluate their
effectiveness [7,30,31]. Formal networks can bring together
people with a common interest into tightly organized
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common. If information flows freely within these networks,
it is more easily taken up in policy development [28,32,33],
but some researchers have pointed out the complexity
of the interactions in such networks [5,20]. Table 1
summarizes the roles played by various stakeholders
according to the literature.
Tomlinson et al. stated that the exact composition and
configuration of the stakeholder groups is country-specific
[34], and stakeholder roles in KT are influenced by the
context in which the evidence, the policy development
process, and the stakeholders interact. Past research has
highlighted the role of stakeholders and the importance of
sustained partnerships, but did not pay adequate attention
to the peculiarities of LICs [10]. This investigation aims to
fill this gap by developing a better understanding of the
perceived roles of the key stakeholders in KT in Uganda.
We hypothesized that stakeholder interactions and
relations influence the uptake of evidence in public health
policy development. Effective partnerships often do not
emerge spontaneously; links need to be established,
a common vision built, capacities strengthened, and
challenges/barriers addressed. By using a qualitative ap-
proach and involving key informants, we addressed the
question of partnerships in KT and explored the perceived
roles of the various stakeholders in KT in Uganda. WeTable 1 A summary of the roles played by various
stakeholders in KT
Stakeholder Roles
CSOs Representing and advocating for the
communities they serve, mobilizing
resources for undertaking research,
undertaking research, disseminating
and facilitating the implementation
of decisions based on evidence
Communities Involvement in setting the research
agenda, demanding the application
of evidence
Media Dissemination of information and
social mobilization
Policy makers Identifying knowledge gaps,
commissioning and guiding research
processes, applying evidence in
decision-making, establishing
institutional platforms for KT




Donors Providing funding for research, KT
activities, and implementation of
research findings
Knowledge brokers Disseminating evidence
Formal and informal networks
and professional bodies
Generating and disseminating
evidencealso evaluated whether and how these stakeholders engage
in partnerships.
Methods
This qualitative study utilized document review and in-
depth interviews conducted between November 2010 and
January 2011 to examine the roles and links among various
stakeholders in KT, as related to public health policy[a]. A
sampling frame of participants was developed by the
research team, in part based on the initial findings of
our document review, which identified various types of
stakeholders. Study participants were then purposively
selected who were deemed to possess relevant characteris-
tics, experience, and/or knowledge about the research
question [36]. Candidate respondents were chosen on the
basis of their institutional affiliations, their seniority in
their current roles, and/or their responsibilities as health
policymakers. Overall, 15 members of the Health Policy
Advisory Committee (HPAC) were interviewed. HPAC
is the policy advisory organ of the health sector; its
membership and number of representatives from each
stakeholder group have been agreed on by all stakeholders
in the health sector. Selected HPAC members included
government officials at the central level (n = 4), service
providers at the district level (n = 1), and representatives
of CSOs including coordinators (n = 2) and service pro-
viders (n = 2). Additionally, representatives from private
for-profit (n = 1) organizations, multilateral donors (n = 3),
bilateral donors (n = 2), researchers (n = 2), journalists/
media (n = 2), and parliamentarians (n = 2) were inter-
viewed. Professional bodies, policy networks, and know-
ledge brokers were not selected because an earlier study on
KT in Uganda indicated that these potential stakeholders
did not have a significant role in KT in Uganda [11].
Officials in the HPAC are the most senior officers in their
institutions/agencies. In the case of private not-for-profit
and private for-profit organizations, HPAC members are
delegated representatives of faith-based medical bureaus
and private health providers, respectively. Districts and
service providers are represented by officers from local
government health services. Researchers were selected on
the basis of their previous work on KT and their focus on
health system development. Journalists were selected based
on their focus on reporting on health issues; they were the
most senior reporters on health issues. The politicians were
members of the social service committee, which deals with
health issues. Detailed information regarding the selected
key informant stakeholders appears in Table 2.
JNO developed the interview guide, which consisted of
open-ended questions intended to examine perceptions
about the roles of various stakeholders in KT, the
challenges faced by these stakeholders, and the availability
of platforms for stakeholder engagement. The research
team reviewed and refined the guide prior to pretesting it
Table 2 Key informant respondents
Stakeholder group HPAC (n) Selected (n) Duration in post
Policy makers (n = 15) Central level MoH 9 4 three for more than 7 years and
one for 3 years
Service providers and health managers
at the service-provision level
District level 1 1 for over 7 years
Facility-based CSOs 2 2 at least 6 years
Non-facility-based CSOs 2 2 6 years and 3 years
Private for-profit providers 1 1 2 years
Donors
Bilateral 4 2 Four for 6 years, one for 6 months,
and one for 2 years
Multilateral 3 3 For at least 7 years
Researchers
Public (from the School of Public Health) 0 1 over 14 years
Private (from a private research group) 0 1 2 years
Journalists (specialized health reporters) 0 2 at least 10 years
Parliamentarians/politicians 0 2 2 years, but previously worked with
the health sector for over 15 years
Total 21
Researchers, journalists and parliamentarians are not members of HPAC.
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World Health Organization (WHO; n = 2), technical
officers in the Ministry of Health (MoH; n = 2), and one
researcher from the School of Public Health. Key infor-
mants were contacted and invited by email or telephone
to participate in the study. All identified respondents
agreed to participate and were interviewed.
All interviews were conducted by JNO, in English and
face-to-face. Interviews were recorded, transcribed verba-
tim, and entered into Microsoft Word for editing as the
first step in “formal” analysis. During the interviews, JNO
made additional notes to record the initial findings and
impressions that were used to augment the transcribed
interviews. The interviews lasted 45 minutes on average.
Deductive content analysis techniques were used to
identify emerging categories linked to the research issues
[37]. As a first step to analysis, JNO and DKM read all
transcribed interviews and developed categories of emer-
ging issues. The study team collaboratively analyzed the
transcripts to identify categories according to the type of
key informant, the emerging issues organized by the
research areas defined in the interview guide, and by the
various stakeholders in KT. Deductive content analysis
was undertaken by JNO, BM, and DKM to assess how
respondents perceived the role of the various stakeholders
in KT and the challenges they face. Patterns in responses
were compared with results from the literature regarding
the roles for and challenges facing the various stake-
holders to identify convergent and other emerging issues.JNO, BM, and DKM initially identified categories and
emerging issues independently, after which JNO and
DKM reviewed and interpreted the findings. Relying on
manifest analytical approach, converging issues were again
reviewed by the rest of the research team and where in-
terpretation differed, consensus was achieved through
revisiting the raw data and discussions. Where necessary,
quotations that best represented emerging issues were
edited slightly for flow, but the meaning of the text was
preserved.
Informed consent was obtained from all respondents
prior to the interviews. Study participants were informed
about the purpose of the study and the scope of the
issues in the in-depth interview guide. Confidentiality
was ensured in data management, and only aggregate
information without subject identifiers is reported. All
data were secured in a safe location accessible only to
the study team. Ethical approval was obtained from the
Institutional Review Board of the Institute of Tropical
Medicine, Antwerp, Belgium (IRB/AC/ac/197) and the
Uganda National Council for Science and Technology
(SS 2920).
Results
The respondents were asked to identify the stakeholders
in KT in Uganda and to report what they felt were the
positive and negative roles played by these stakeholders
(Table 3). Below we present specific issues that were
identified for each group of stakeholders.





Challenges faced in playing
their role in KT
CSOs Using research results (10) May de-campaign evidence
if they are not convinced (2)
Lack of capacity, weak internal
organization, lack of independence
Advocating with policy makers to
implement evidence (8) If not given proper information,




Liaising with the media (1)
Generating research topics (1)
Communities Can demand that evidence be
implemented or demand that a
policy be developed (6)
Can be disruptive if results do
consider community-contextual
issues (1)
Currently not able to engage in
research policy processes
Contributing to development of
the research agenda (6)
Can participate in research (1)
Media Disseminating research results (15) Misrepresenting evidence (5) Not well organized and are
communicating to a public that is
not strong enough to respondPutting forward community
views (4)
De-campaigning implementation




Policy makers Using evidence in developing
policies and implementation (12)
If evidence is not in their favor,
can de-campaign it or
misrepresent results (2)
Inclined to serve political interests
May remain unconcerned about
available evidence and play a
passive role (1)
Establishing structures that can
improve uptake of research (e.g.
knowledge brokers), developing




Participating in research (1)
Parliamentarians/politicians Demanding implementation of
evidence (8)
Focus may differ; if they see
that the available evidence does
not favor their objectives and
may lead to the loss of votes,
they will not support the evidence.
If they stand to benefit, they will
support the evidence (4)
Difference in objectives; technical
objectives may differ from political
objectives
Advocating for funding to
implement recommendations (4)
Mobilizing and disseminating
evidence to their communities (4)
Researchers Undertaking research (14) Corruption affects the research
community to the extent that
they may even provide
misleading results (1)
Balancing satisfying academic
interest and community needs
Research users (1)
Donors Providing funding for research (16) May carry out research that
does not focus on local
needs (3)
Availability of institutionalized
platforms for setting research
agendas and engaging in KT
under strong MoH leadership
Providing funding for implementation (9)
At times they work toward
fulfilling agency agendas (2)
Undertaking research activities (5)
May refuse to fund implementation
of certain recommendations, for
whatever reasons (1)
Encouraging the development of
evidence-based polices (2)
WHO provides global evidence that
guides policy development in
countries (2)
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Table 3 Identified positive and negative roles for various stakeholders (Continued)
Can make financial commitments
to support implementation of
evidence but fail to meet them (1)
Implementing research recommendations (1)
Influencing the research agenda (1)
Failure to contextualize
global knowledge (1)
May bring in global knowledge (1)
Private health providers Using evidence to make investment
decisions (1)
Weak internal organization
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Almost half of the respondents (n = 10) mentioned the
use of research results as a role that CSOs can play in
KT. A MoH official remarked that “civil society, most
especially those concerned with health issues, have the
capacity to implement research recommendations.” A
donor official stated that “civil society can mobilize
dedicated funding and can actually help to implement
research findings.”
Eight respondents also included advocating with policy
makers to implement evidence, developing policies that
incorporate evidence, and community mobilization among
the roles of CSOs in KT.
A civil society respondent remarked that “civil society
is very key; they can disseminate research, advocate
with policy makers, mobilize communities, and liaise
with the media.”A MoH respondent also emphasized this role, stating
that “civil society, most especially those concerned with
health issues, should be involved in most decisions
because they have the capacity to mobilize
communities to support policy development and
implementation.”
Regarding CSOs undertaking research, one respondent
stated that CSOs are limited by their weak position; the
MoH does not believe that they have the capacity to
undertake high-quality research. A CSO respondent stated,
“Sometimes we have failed to commission studies because if
these studies are done by us, the attitude in the MoH is
such that they may not believe in them, but if they are
performed by WHO or UNICEF, then the big name carries
the day. So, many times, we have been discouraged at the
pre-research stage.”
Negative roles that CSOs may play in KT were also
mentioned. These roles included undermining evidence
that they are not convinced about and causing confusion
in the community if they are not given proper information.
One respondent, who is a researcher, articulated
challenges facing CSOs in KT, with the exception of
religion-affiliated bureaus. This respondent was concerned
about their lack of capacity, weak internal organization,
and lack of independence. Most CSOs are funded bydonors, and some receive funding from government and
that compromises their independence. The respondent
said, “Civil society is not a big voice; they are currently
just being imposed on us by donors. They lack funding
independent of the government and lack technical capacity.
They are not organized well enough to engage in policy
development, can’t harness their power to influence policy
processes, and may not even be educated enough.”Communities
Six respondents expressed the opinion that the com-
munities’ main roles were to demand implementation
of evidence and to contribute to the development of the
research agenda.
A donor respondent stated that “communities can
advocate for their needs, speaking up when the policy
that should be in place is not being implemented.
[They] can help researchers to better define their
questions, and can also demand to know what research
is being done and whether it will benefit them.”A civil society respondent said that “communities are
the beneficiary of the research; they can demand that
evidence is implemented through political leaders like
members of parliament, through demonstrations, but
they can also contribute to development of the
research agenda.”
One respondent mentioned that this role requires that
researchers and policy makers understand how to engage
communities. In addition, there must be organized com-
munity structures that enable communities to participate
in research processes.
However, one researcher raised concerns regarding
whether the community was able to play any role in KT,
stating that “the community is dislocated from the main
machinery, both in terms of undertaking research but
also in policy development. Their contribution is very
small, they are not key stakeholders. Power and decision
making is very centralized, and even decentralization
that was meant to enhance community participation has
yet to be achieved. Communities have no political voice,
partly because of poverty and lack of education.”
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A majority of respondents expressed the idea that the
role of the media is to disseminate evidence, and also to
bring the views of the community to policymakers.
A MoH respondent said that “the media definitely
play a key role in dissemination, informing people
about new research findings. They put forward the
views of the community.”A private for-profit respondent highlighted the
dissemination role of the media as “the media have a
positive influence; they are the means of transfer of
information, they are a communication channel to
the public.”A journalist remarked that “the media act as a public
watchdog; they can make something a national issue.
They are also a pressure group; they can mobilize for
action and also sensitize the public about the research
findings. In about ten minutes, knowledge can be
transferred instantaneously and simultaneously to the
whole world.”
Respondents identified several negative roles of the
media, such as misrepresenting data when evidence is
passed on to the media in a poorly packaged form.
A private for-profit respondent said that “the way
you engage in dialogue with the media and the
way information is packaged will determine the
impact of the media. If information is poorly
packaged and poorly passed on, they will
misrepresent the evidence. If you don’t want
them to provide wrong information, give the
correct information.”A donor stated that “the media can have a negative
influence if they misrepresent your results or the ideas
of your research, e.g. telling the public that they have
come to us as guinea pigs in reference to a new
research project like a drug trial.”A civil society respondent indicated that “the media
can play a negative role by misrepresenting
information for their own interests, so you need to
bring them on board. We should work hard as
professionals to have the media on board; we need to
create time for them.”
In order to minimize misrepresentation, one re-
spondent mentioned the need to carefully select mes-
sages and to provide written messages as opposed to
verbal communication.The challenges hampering the effectiveness of the
media in KT included not being well organized and
communicating with a public that is not strong enough
to respond. One researcher stated, “The media are not
very strong. They should be the civil watchdog reporting
to the public (…) the public is not organized enough to
follow up on what is reported. In this case, it weakens the
role of the media. The media should work hand-in-hand
with the public, but the public is weak and this also
weakens the media. An example is drug thefts that have
been reported in papers, but the public has never come
up to demand accountability.”
Government policymakers
Many respondents (n = 12) stated that the role of govern-
ment policy makers in KT is to make use of evidence and
to identify knowledge gaps. One respondent said that
“government policy makers and technical ministries play a
role in policy formulation, but they are also the implemen-
ters. They should use evidence to formulate policies.”
Five respondents mentioned that government policy
makers should put in place structures and platforms that
can improve the uptake of research and play a stewardship
role in the generation and uptake of evidence. A donor
respondent stated that “they should ensure that dialogue
takes place, they should take a stewardship role, ensure
that research results are discussed and use them for policy
development.”
Some negative roles identified by respondents included
ignoring or even misrepresenting evidence that is not in
their favor, as illustrated in the following quote by a civil
society respondent, “they can play a negative role if the
research result is not in their favor. If it is not in their
favor they can actually ignore it. The other negative role
is they can misinterpret it to suit whatever side they want
to lean against.”
Another negative role indicated by respondents was
the inclination to serve political interests irrespective of
available evidence. A journalist said that “they tend to
operate in the political domain, which limits them
depending on the regime. They are sometimes insensitive
to some societal needs, and they become negative on
things that should really be supported.”
Politicians/parliamentarians
Respondents perceived that the main role of parliamen-
tarians is to ensure implementation by demanding that
evidence is implemented (n = 8) and by advocating for
funding for its implementation and dissemination (n = 4).
A civil society respondent stated that “parliamentarians
can mobilize communities; each parliamentarian comes
from a constituency, and can mobilize his/her people to
demand the implementation of evidence. But they also
play a role in dissemination; they can disseminate evidence
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the MoH to implement evidence.”
Differences in the objectives being pursued underpinned
a negative role attributed to politicians. Four respondents
mentioned that the priority of politicians is to secure the
electorate’s vote; these respondents felt that if the evidence
is contrary to this objective, the politicians will not
support it.
For example, a MoH respondent said “People fear to
carry out research that is against politicians’ interests,
they fear annoying them. If findings are in their favor,
they can help you push the implementation of
recommendations. However, politicians will stop
research implementation if it is against their
interests.”A private for-profit respondent stated, “Politicians
tend to have inclinations. Policies are twisted
towards political interests and in that sense, they
can have a negative influence. Political peddling
has an impact on how that policy is going to be.
If they are open towards evidence and understand
the value of research, they can play a positive
role.”
Researchers
Although the main role of researchers was identified
as undertaking research, respondents pointed out that
researchers need to perform research in collaboration
with beneficiaries like the MoH. Respondents were also
concerned about the focus of the research community on
satisfying academic interests rather than community needs.
In addition, respondents highlighted the issue of corruption
affecting the research community, which is understood
to occur when funds are provided and inferior-quality
research or misleading evidence is produced.
Donors
Respondents described the role of donors in KT as
providing funding for undertaking research (n = 13) and
providing funding for implementing research findings
(n = 16), as illustrated in the following quotes. First, a
donor respondent said,
“Donors should fund research, although it must be in
line with the priorities identified in the research
agenda. They should fund dissemination activities.
They should also contribute to funding the
implementation of recommendations.”Second, an MoH respondent stated that “donors are
key for funding, and can provide funds for the
implementation of research recommendations.”Third, a journalist said, “When it comes to the
generation and use of evidence, donors can
comfortably perform in funding.”
Although undertaking research was identified as a donor
role by five respondents, respondents also were concerned
about the local relevance of donor-supported research.
A civil society respondent remarked, “They should not
just bring research of their interest. The north-to-south
collaboration in research should be fine-tuned to make
research more responsive to knowledge gaps as
perceived at the local level,”A MoH respondent stated that “donors may impose a
research agenda on us that is not our priority.”
A private for-profit respondent raised the issue of the
donor agency agenda overtaking local interests in the
research process, stating, “Donors are sometimes bent
towards fulfilling agency agendas. If our priorities are not
clear, support may be wasted through duplication and
confusion.”
Almost all respondents (n = 18) stated that stakeholders
need to work together in a partnership right from setting
the research agenda, through the research or knowledge
generation process, dissemination and applying the know-
ledge. Seventeen respondents indicated that institutional-
ized platforms bringing together all relevant stakeholders
are necessary to ensure that partnerships are effective;
they reported that these platforms were lacking, and that
the leadership of the MoH in guiding research processes
and applying evidence was weak.
A MoH respondent said, “There is no systematic
dialogue between policy makers and researchers. Other
stakeholders must be involved as well. The Uganda
National Health Research Organization that should
coordinate this exercise is still weak.”A civil society respondent declared that “there must be
a continuous rapport between researchers and the
government. I think when researchers give evidence,
that’s where it stops, there must be continuous
networking and linkage.”Another civil society respondent stated, “Partnership
is very much necessary, the community is not involved,
the community puts in little yet all should be included
in policy development.”These platforms would ensure systematic dialogue.
One civil society respondent emphasized that “we
need to have a research advisory network in place.
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knowledge brokers, and policy makers. In this way, it
would be easy to have a research agenda agreed on by
all stakeholders that will be followed and results well
disseminated and implemented.”
Discussion
Our study has yielded useful insights into the roles of
the various stakeholders in KT in Uganda. The literature
emphasizes that the roles assigned to stakeholders should
correspond to their skills and expertise [38]. The need for
systematic and meaningful involvement of stakeholders
in partnerships, working in a complimentary manner to
achieve a common objective, has also been raised [34].
This goal calls for establishing inclusive platforms with
appropriate leadership to bring all stakeholders together.
In addition, there must be mechanisms for addressing
conflicts of interest and guarding against undue influence.
Deslie et al. noted that the weaknesses facing various
stakeholders must be addressed, their skills must be
enhanced, and information must be shared in under-
standable formats if stakeholders are to play their roles
effectively [13].
Respondents noted that the uptake of evidence in public
health policy development and implementation can be
performed by government policy makers and CSOs. In the
case of CSOs, these findings are similar to what has been
identified in literature [13,16]. Their ability to mobilize
funding and implement health programs can enhance their
contribution to implementing evidence. However, other
researchers caution that their capacity to engage in policy
development is limited, especially in LICs, and questions
about the legitimacy of their policy positions and account-
ability have been raised [39]. Policy makers serve a leader-
ship role in policy development and are definitely central
to the uptake of evidence in policy development. However,
literature has shown that they often work under severe
time constraints and political pressure, which may not
allow enough time for the application of evidence [40].
This issue requires the balancing of time pressures, timely
provision of evidence, and implementing decisions. The
potentially superficial understanding of the subject matter
by policy makers, who are often responsible for several
areas, is also a documented challenge [40]; researchers can
minimize the effect of this superficial understanding by
summarizing evidence in brief, digestible formats.
The dissemination of evidence was identified as a role
that can be played by the media, CSOs, and parliamentar-
ians. In the case of the media, our respondents highlighted
the risk of misrepresenting evidence and a weak public as
compromising the media’s effectiveness. The role of the
media in disseminating evidence has been documented,
and researchers have noted that more contact with the
media will help strengthen the media’s capacity forscience reporting [41]. Indeed, an earlier study in Uganda
noted the poorly coordinated efforts of researchers and
communities to reach the media, concluding that the
media is a powerful ally that is under-utilized by public
health professionals [42]. The literature emphasizes the
importance of presenting evidence to CSOs in a clear and
simplified format if they are to effectively disseminate
evidence; in addition, regular updates need to be provided
throughout the research process [16,43]. These actions
will safeguard against the negative roles identified in this
study, especially misrepresentation of evidence and the
creation of confusion in the community. Although the
literature indicates that researchers can engage in dis-
semination, our respondents did not identify this role.
Researchers may instead focus on the generation of user-
friendly research products and improving the engagement
with the media and with CSOs. This focus reflects the
results of studies of the process of translating research
on male medical circumcision and prevention of mother-
to-child transmission into policy; Ssengooba et al. reported
that researchers were found to be media “shy” [26]. Some
studies have reported that researchers can also act as policy
entrepreneurs by organizing themselves into networks
that can engage policy makers. In instances in which this
strategy was successful, some of the policy makers had
research backgrounds [33]. This strategy was not mentioned
by our respondents.
Advocating for the implementation of evidence, exerting
pressure on policy makers, and mobilizing communities
were identified as roles for politicians/parliamentarians
and CSOs. These roles are similar to those previously
identified in the literature [13,15,16]. CSOs and parlia-
mentarians are nearer to communities and are supposed
to represent community interests. CSOs have been shown
to be effective advocates once empowered with evidence;
they have been able to mobilize communities to demand
government accountability and to encourage donors to
focus on country priorities [13]. Respondents in our study
noted the need for CSOs to be funded outside of the
government to ensure independence. However, the depend-
ency of CSOs on donors to finance their operations, espe-
cially in LICs, will remain a constraint in that CSOs may be
hesitant to take a position that is against the position of
their funders [17]. Regarding politicians/parliamentarians,
effective realization of their roles continues to be challen-
ging given the nature of political systems in LICs. Political
ideology and the tendency to respond to the demands
of constituencies or electorates, irrespective of the evi-
dence, are among the challenges that must be overcome
[27]. Young previously highlighted the need to better
understand the political processes of LICs in order to
understand the role of evidence in policy making [27]. The
community has been noted to be able to exert pressure on
policy makers to respond to evidence [44], which can be
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communities.
Although previous research revealed that undertaking
research is a role that could be played by CSOs [13,16],
it was not identified as a major role of CSOs in our study.
This result reflects the often weak linkage between CSOs
and the research community and the limited scope of their
research, which is mainly limited to evaluation of their
programs [13]. The capacity of CSOs to engage in research
can only be encouraged if investments can be made with
respect to training, mentorship programs, or through
formal partnerships between communities and universities
that link CSOs with academic researchers. Community
participation in setting the research agenda, which was
highlighted in this study, has also been identified by other
researchers [45,46], who noted that this participation may
improve the responsiveness of research to community
priorities. Several challenges confronting researchers were
identified by our respondents, including the risk of dispro-
portionate focus on academic interests and failing to
address community priorities; these challenges were also
pointed out by other researchers [43,44]. In addition, the
tradeoff between producing high-quality research and the
time-constrained nature of the policy-making process is
often difficult to achieve.
In our study, funding research and implementing evidence
were identified as roles played by donors, a finding similar
to other studies [3,21]. The funding role of donors in
KT has long been seen as potentially supportive and disrup-
tive at the same time. In some instances, funding has been
used to influence research agendas and policy development
in LICs [42]. For example, Burris et al. reported that
the funding requirements of donors in Ghana were the
strongest impetus for the uptake of evidence in guideline
formulation for HIV care [44]. Similarly, the decision to
change Uganda’s malaria treatment policy was heavily
influenced by the availability of funding from the Global
Fund against AIDS, Tuberculosis, and Malaria [47]. Many
LICs depend heavily on foreign aid to fund health services,
allowing donors to exert undue influence on research pro-
cesses and programming decisions. Some researchers have
highlighted the need to better understand the interface
between development agencies and national processes in
LICs [3]. Donor funding can definitely contribute positively
to research and policy development in LICs, but govern-
ments must be able to effectively fulfill their stewardship
role [48]. This undue influence of donors has been con-
trolled to some extent when governments have established
structures to develop research agendas through inclusive
partnerships [34]. We were surprised to note that no
respondent mentioned funding of research and implemen-
tation of evidence as a role for governments.
In our study, there was also no mention of professional
bodies and informal policy networks as stakeholders inKT. Reasons for this omission may include the relative
weakness of professional bodies in Uganda and the fact
that they are not much known outside the MoH. In
addition, professional bodies are not very active in
public-health policy making, which was the focus of this
study, as has been reported for several African countries
[49]. Their role is more pronounced in the development
of clinical practice guidelines, and positive contributions
have been documented [33]. Knowledge brokers were
not identified as stakeholders by the respondents of
the present study, perhaps because this is a relatively
new concept; there are currently no knowledge brokers
active in Uganda.
In this study, government policy makers, CSOs, the
media, parliamentarians/politicians, communities, re-
searchers, and donors were identified as stakeholders
in KT for public health policy in Uganda. The roles played
by these stakeholders and the challenges that remain to be
overcome are summarized below.
Role: Uptake of evidence in public health policy
development and implementation
For CSOs to effectively engage in policy development,
their skills must encompass navigating the political terrain,
engaging policy makers, and networking, which call for
high levels of internal organization and independence
[16,39]. Uptake of evidence by policy makers could be
improved by recruiting advisors and/or establishing think
tanks to synthesize evidence in simple, digestible formats,
as already attempted in some LICs [27]. The links among
policy makers, researchers, and CSOs have long been
known to be potentially beneficial, and should be strength-
ened [5,24] to enable systematic information-sharing and
synergy in evidence implementation [39]. Policy makers
need to put in place the institutional frameworks and
platforms for engagement that will enhance greater
ownership and application of evidence by policy makers
and politicians [11].
Role: Dissemination
The risk of misrepresentation of evidence by the media
must be minimized through improved dissemination of
evidence, preferably in written formats rather than verbal
communication alone. The literature underscores the
critical impact of communicating evidence in a clear,
conclusive, and accessible way [16,43]. Further, platforms
need to be established for systematic engagement and
information-sharing among researchers, policy makers,
and the media. In order to improve the impact of the
media, there must be parallel efforts to strengthen the
public’s response to media messages.
For CSOs to strengthen their contributions as dissemina-
tors of evidence, evidence must be presented to CSOs in
clear and adapted formats, and regular updates should be
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with accurate information through targeted dissemination
and regular updates.
Role: Advocating for the implementation of evidence,
exerting pressure on policy makers, and mobilizing
communities
To achieve this role, CSOs need to be independent and
funded independently of government channels. The links
between parliamentarians and community structures
on the one hand and between parliamentarians and re-
searchers on the other must be strengthened to ensure
that politicians are provided with accurate information.
Further, there is a need for mechanisms of targeted dis-
semination of evidence to communities in simplified
and appropriate formats. Platforms for researchers, policy
makers, and communities to effectively engage with com-
munities and for organizing communities to be able to
engage in policy processes must be put in place [45].
Role: Undertaking research
Structures must be established to enable communities to
participate in research processes; these structures should
include links between communities and researchers.
Communities must be organized, and consultative mecha-
nisms need to be established for them to engage in setting
research priorities. For researchers, institutional platforms
should be established between researchers and policy
makers so that researchers appreciate both the policy-
making process and the pressure under which policy
makers work. At the same time, these platforms could
help policy makers to better appreciate the research process
and the constraints faced by researchers. Such platforms
provide learning opportunities for all actors [26]. The
failure to focus on community needs and local priorities
can be addressed through mechanisms for inclusion in
the setting of research priorities.
Role: Funding research and implementation of evidence
In order to focus donor support on the priorities of the
country, governments need to establish structures to
develop research agendas through inclusive and par-
ticipatory partnerships. The advocacy and community-
mobilization roles of CSOs could also be employed to
ensure that donor funding supports locally identified
priorities.
Study limitations
In the interviews, no references were made to either a
specific research study or to actual policy, which may
have influenced the respondents’ reflections on the KT
process in Uganda by keeping the discussion at a more
abstract level. However, it could also be argued that
mentioning a specific policy could have induced therespondents to be more anecdotal in their responses.
We also note that some respondents may have dual roles
in KT. For instance, a researcher may be working for
civil society, and therefore represent two stakeholder
groups at the same time. The influence of these dual roles
was not explored in this study; it could be considered a
strength as much as a weakness of this investigation, in
that this influence may have enriched the reflection more
than it limited it. We did not use the Delphi method to
identify the shared views of the various stakeholders and
to reach theoretical saturation. While such a process may
have its benefits, we believe that in-depth interviews
allowed more efficient exploration of the views of the vari-
ous groups, which in a second phase can still be presented
to a wider group through a Delphi process. Finally, this
study focused on KT in reference to public health policies
and may not be representative of other fields such as
clinical interventions.
Conclusions
Previously, Sauerborn et al. emphasized the importance
of considering the needs of various stakeholders [10].
We argue that there is a need to take into consideration the
roles that the various stakeholders are best positioned to
play in KT. Linkages must be built and necessary platforms
put in place to achieve synergy among stakeholders in KT.
At the same time, the challenges faced by the various
stakeholders need to be overcome, and relevant capacities
must be built if they are to play their roles effectively.
Endnotes
a In the health sector in Uganda, policy development and
implementation of health programs have been undertaken
within a partnership under the sector-wide approach since
2000 [35]. The process of policy development usually begins
with discussions within technical working groups com-
prised of government officials, donors, civil society repre-
sentatives, and private for-profit health providers. Technical
working groups propose options that are discussed further
in the HPAC, the policy advisory body of the health sector.
The HPAC consists of senior government officials from the
central and district levels and representatives from donor
agencies and the private not-for-profit and private for-profit
sectors. The HPAC makes final decisions regarding the
adoption of policy options.
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